24-Week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint pain
Clark KL, Sebastianelli W, Flechsenhar KR, Aukermann DF, Meza F, Millard RL, Deitch JR, Sherbondy PS, Albert A
Published in Current Medical Research and Opinion
Methodology
Randomized, double-blind, placebo-controlled trial of 10 g/day collagen hydrolysate for 24 weeks in athletes with activity-related joint pain; visual analogue pain scales.
Key Findings
Athletes taking collagen hydrolysate reported significantly greater reductions in joint pain at rest, when walking and when carrying objects than placebo.
Conclusions
Collagen hydrolysate reduced activity-related joint pain in athletes over 24 weeks.
Limitations
Subjective pain endpoints only, no imaging or structural outcomes; manufacturer-funded; healthy athletic population.
Supplements Studied
Collagen hydrolysate reduced activity-related joint pain in athletes over 24 weeks.
Outcomes Measured
Athletes taking collagen hydrolysate reported significantly greater reductions in joint pain than placebo.
Related Health Concerns
Study Details
Access Study
Disclosures
Funding
GELITA Health Products (manufacturer)
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.